Nurix Therapeutics Inc (NRIX) — Capital Reinvestment Ratio
Nurix Therapeutics Inc (NRIX) has a Capital Reinvestment Ratio of 0.10x as of November 2023, meaning it reinvests 0% of its operating cash flow ($26.69 Million) in capital expenditures ($2.58 Million). Check Nurix Therapeutics Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Nurix Therapeutics Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Nurix Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Nurix Therapeutics Inc.
Annual Capital Reinvestment Ratio for Nurix Therapeutics Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Nurix Therapeutics Inc from 2019 to 2019. See NRIX FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 2.75x | $601.00K | $1.65 Million | — |